3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
7
Rectal Neoplasms
7
Oropharyngeal Neoplasms
7
Head and Neck Neoplasms
6
Carcinoma, Non-Small-Cell Lung
5
Pancreatic Neoplasms
3
Lung Neoplasms
3
Hypopharyngeal Neoplasms
3
Glioblastoma
3
Esophageal Neoplasms
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Radiation Injuries
2
Pathologic Complete Response
2
Nasopharyngeal Carcinoma
2
Mouth Neoplasms
2
Laryngeal Neoplasms
2
Vaginal Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Tobacco Use Disorder
1
Thymoma
1
Smoking Cessation
1
Smoking
1
Small Cell Lung Carcinoma
1
Sinonasal undifferentiated carcinoma
1
Sinonasal Squamous Cell Carcinoma
1
Resectable Esophageal Cancer
1
Rectal Malignant Neoplasms
1
Postoperative Complications
1
Interventions
pembrolizumab
137
Nivolumab
116
Ipilimumab
68
Cyclophosphamide
33
Specimen Handling
31
Magnetic Resonance Spectroscopy
28
trametinib
23
binimetinib
22
fludarabine
21
Interleukin-2
20
dabrafenib
19
relatlimab
17
encorafenib
17
Biopsy
17
CTLA-4 Antigen
16
cemiplimab
15
atezolizumab
15
aldesleukin
15
Radiosurgery
15
fludarabine phosphate
14
Opdualag
14
Radiotherapy
11
lenvatinib
10
Blood Specimen Collection
10
lifileucel
9
Paclitaxel
8
Cisplatin
8
Bevacizumab
8
spartalizumab
7
cobimetinib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
Chemoradiotherapy
×
1 year
×
Clear all
No trials found.